Shares of Presurance Holdings and InterCure Ltd. Both received notices from Nasdaq indicating they are not in compliance with minimum bid price requirements, according to separate announcements on Wednesday, March 6, 2026.
Presurance Holdings was informed of the deficiency by Nasdaq on March 6, 2026, regarding its stock’s closing price falling below the $1.00 threshold. The company is evaluating its options, which may include a plan to regain compliance. This development comes as investors closely monitor the performance of smaller-cap stocks amid broader market fluctuations.
Similarly, InterCure also received a notification from Nasdaq on March 6, 2026, stating its shares were trading below the minimum bid price. InterCure is also reviewing available options to address the issue and restore compliance with Nasdaq listing rules. The news reflects ongoing scrutiny of listed companies’ financial health and market capitalization.
Both companies have a set timeframe to submit a compliance plan to Nasdaq or risk potential delisting. The situation underscores the importance of maintaining sufficient share price levels for companies listed on major exchanges.
